(S)-N-(p-methoxyphenylsulfonyl)proline | 81242-27-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (S)-N-(p-methoxyphenylsulfonyl)proline
• 英文别名: Proline, 1-[(4-methoxyphenyl)sulfonyl]-；(2S)-1-(4-methoxyphenyl)sulfonylpyrrolidine-2-carboxylic acid
• CAS: 81242-27-5
• 化学式: C₁₂H₁₅NO₅S
• mdl: MFCD09863519
• 分子量: 285.321
• InChiKey: LWZATQDWEXAGQR-NSHDSACASA-N

物化性质

• 沸点：
  491.7±55.0 °C(Predicted)
• 密度：
  1.403±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.416
• 拓扑面积：
  92.3
• 氢给体数：
  1
• 氢受体数：
  6

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  (S)-N-(p-methoxyphenylsulfonyl)proline 在 氯化亚砜 、 三乙胺 、 N,N-二甲基甲酰胺 作用下， 以 醋酸异丙酯 为溶剂， 反应 3.0h， 生成 (2S)-N-(3,5-二甲基苯基)-1-[(4-甲氧基苯基)磺酰基]-2-吡咯烷甲酰胺
  参考文献：
  名称：

  试点植物规模上脯氨酸酰胺Orexin受体拮抗剂的短合成

  摘要：

  描述了三步全望远镜合成N-磺酰基脯氨酸酰胺（一种人类orexin受体的非肽拮抗剂）的方法。讨论了从药物化学路线到生产240公斤1的过程，重点是经济有效地形成酰胺键并鉴定出新的多晶型物。使用绿色指标比较路线。

  DOI：

  10.1021/op500277s
• 作为产物：
  描述：

  (S)-1-(4-Methoxy-benzenesulfonyl)-pyrrolidine-2-carbonyl chloride 在 sodium hydroxide 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 24.5h， 生成 (S)-N-(p-methoxyphenylsulfonyl)proline
  参考文献：
  名称：

  Preparation of both enantiomers of 1-allyl-1,2,3,4-tetrahydro-β-carboline using allyltin reagents and a chiral auxiliary derived from l-proline

  摘要：

  beta -Carboline, which had an acyl group derived from L-proline at the 9-position, reacted with allyltributyltin and 2,2,2-trichloroethyl chloroformate, to afford an 1-allyl-1,2-dihydro-beta -carboline derivative in a diastereo selective manner. The chiral acyl group at N-9 was readily eliminated by aqueous alkali to give a corresponding carboxylic acid. The formed 1-allyl-1,2-dihydro-beta -carboline was transformed via two reduction steps to 1-alkyl-1,2,3,4-tetrahydro-beta -carboline in high ee. When the allylation was carried out using tetraallyltin instead of allyltributyltin, the stereoselectivity was reversed, and the antipode of the allyl adduct was obtained in high yield and ee in the presence of tin(IV) tetraiodide. Thus, it was found that both enantiomers of 1-allyl-beta -carboline were obtained in good enantioselectivities by the use of the same chiral auxiliary. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(01)00684-6

文献信息

• Asymmetric Cyclopropanations by Rhodium(II) <i>N</i>-(Arylsulfonyl)prolinate Catalyzed Decomposition of Vinyldiazomethanes in the Presence of Alkenes. Practical Enantioselective Synthesis of the Four Stereoisomers of 2-Phenylcyclopropan-1-amino Acid
  作者：Huw M. L. Davies、Paul R. Bruzinski、Debra H. Lake、Norman Kong、Michael J. Fall

  DOI：10.1021/ja9604931

  日期：1996.1.1

  to]dirhodium. The carbenoid structure has a critical effect on the degree of asymmetric induction, and the combination of a small electron-withdrawing group such as a methyl ester and an electron-donating group such as vinyl or phenyl resulted in the highest levels of enantioselectivity. The use of electron neutral alkenes and pentane as solvent also enhanced the enantioselectivity of the process.

  N-(芳基磺酰基)脯氨酸铑在烯烃存在下催化乙烯基重氮甲烷的分解导致以高度非对映选择性和对映选择性模式合成官能化环丙烷的非常通用的方法。进行了详细研究以确定控制该过程的对映选择性的关键因素。使用环状 N-(芳基磺酰基)氨基酸作为二铑催化剂的配体获得了最高水平的对映选择性，优化的催化剂是四[N-[(4-十二烷基苯基)磺酰基]-(L)-脯氨酰]二铑。卡宾结构对不对称诱导的程度有关键影响，小的吸电子基团（例如甲酯）和给电子基团（例如乙烯基或苯基）的组合导致最高水平的对映选择性。使用电子中性烯烃和戊烷作为溶剂也提高了该过程的对映选择性。这种化学的合成效用...
• [EN] HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1<br/>[FR] AMIDES HÉTÉROCYCLIQUES EN TANT QUE MODULATEURS DE LA TRPA1
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2010141805A1

  公开（公告）日：2010-12-09

  Certain heterocyclic amide compounds are described. The compounds may be used in pharmaceutical compositions and methods for treating disease states, disorders, and conditions mediated by TRPA1 activity, such as pain, arthritis, itch, cough, asthma, or inflammatory bowel disease.

  描述了某些杂环酰胺化合物。这些化合物可用于制备药物组合物，以及用于治疗由TRPA1活性介导的疾病状态、紊乱和条件，如疼痛、关节炎、瘙痒、咳嗽、哮喘或炎症性肠病的方法。
• In Vitro Aldose Reductase Inhibitory Activity of Substituted N-Benzenesulfonylglycine Derivatives
  作者：Jack DeRuiter、Abram N. Brubaker、Martha A. Garner、Jeffrey M. Barksdale、Charles A. Mayfield

  DOI：10.1002/jps.2600760213

  日期：1987.2

  A number of N-benzenesulfonylglycines, alanines, sarcosine, and prolines, which contain the minimum pharmacophore moieties necessary for aldose reductase inhibitory activity, were prepared and tested in the rat lens assay. In this assay, the benzenesulfonylglycines are considerably more potent than the corresponding alanine and sarcosine derivatives which, in turn, are more active than the proline

  制备了许多N-苯磺酰基甘氨酸，丙氨酸，肌氨酸和脯氨酸，它们含有醛糖还原酶抑制活性所必需的最小药效团部分，并在大鼠晶状体测定中进行了测试。在该测定中，苯磺酰基甘氨酸比相应的丙氨酸和肌氨酸衍生物的效力明显更高，而丙氨酸和肌氨酸衍生物的活性又高于脯氨酸类似物。在单取代的苯磺酰基甘氨酸中，2-硝基和4-氨基衍生物的活性最高，其50％抑制浓度（IC50）值分别为13和16 microM。评价的最有效的衍生物是β-和α-萘磺酰基甘氨酸，IC50值分别为0.4和1.3 microM。
• PROLINE SULFONAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS
  申请人：Boss Christoph

  公开号：US20130150424A1

  公开（公告）日：2013-06-13

  The present invention relates to (S)-proline sulfonamide compounds of formula (I) wherein R 1 and R 2 are as described in the description, or pharmaceutically acceptable salts thereof, for use in the prevention or treatment of diseases or disorders related to the orexin system. The present invention also relates to the use of (S)-proline sulfonamide compounds of formula (II) as pharmaceuticals, to pharmaceutical compositions comprising compounds of formula (II), and especially their use in the prevention or treatment of diseases or disorders related to the orexin system.

  本发明涉及公式（I）中的（S）-脯氨酸磺酰胺化合物，其中R1和R2如说明书中所述，或其药学上可接受的盐，用于预防或治疗与促进素系统相关的疾病或障碍。本发明还涉及使用公式（II）中的（S）-脯氨酸磺酰胺化合物作为药物，制备含有公式（II）化合物的药物组合物，特别是它们在预防或治疗与促进素系统相关的疾病或障碍方面的使用。
• C-PROTEINASE INHIBITORS FOR THE TREATMENT OF DISORDERS RELATED TO THE OVERPRODUCTION OF COLLAGEN
  申请人：FIBROGEN, INC.

  公开号：EP0845987A1

  公开（公告）日：1998-06-10